[Hartnup disorder: Pathogenesis, pathophysiology, and therapy].
Ohura
Toshihiro
T
Department of Pediatrics, Tohoku University, Graduate School of Medicine.
D026921:Amino Acid Transport Systems, Neutral / Q000235:genetics* / Q000502:physiology; D002648:Child; D003001:Cloning, Molecular; D005838:Genotype; D006250:Hartnup Disease / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D009154:Mutation; D009536:Niacinamide / Q000008:administration & dosage; D010641:Phenotype; D012701:Serotonin / Q000172:deficiency; D014364:Tryptophan / Q000172:deficiency
D026921:Amino Acid Transport Systems, Neutral; C491436:SLC6A19 protein, human; D009536:Niacinamide; D012701:Serotonin; D014364:Tryptophan